We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.04B
AUM Growth
+$78.5M
Cap. Flow
-$21.3M
Cap. Flow %
-1.05%
Top 10 Hldgs %
16.88%
Holding
318
New
26
Increased
78
Reduced
63
Closed
17

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$18.2M
2
NVRO
NEVRO CORP.
NVRO
+$7.45M
3
EXAS
Exact Sciences
EXAS
+$6.7M
4
ZEN
ZENDESK INC
ZEN
+$5.02M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.99M

Top Sells

Rank Stock Value
1
VAL
Valspar
VAL
+$12.7M
2
AKAM icon
Akamai
AKAM
+$6.27M
3
SYF icon
Synchrony
SYF
+$5.49M
4
HRL icon
Hormel Foods
HRL
+$5.4M
5
ESRX
Express Scripts Holding Company
ESRX
+$4.27M

Sector Composition

Rank Sector Weight
1 Industrials 19.97%
2 Healthcare 18.77%
3 Technology 17.98%
4 Consumer Discretionary 12.95%
5 Financials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MZTI
226
The Marzetti Company
MZTI
$3.11B
$1.3M 0.06%
10,600
– –
DY icon
227
Dycom Industries
DY
$12.3B
$1.28M 0.06%
14,300
+1,800
+14% +$175K
ESS icon
228
Essex Property Trust
ESS
$18.5B
$1.27M 0.06%
4,953
– –
GDOT icon
229
Green Dot
GDOT
$745M
$1.25M 0.06%
32,400
+12,200
+60% +$441K
PRAA icon
230
PRA Group
PRAA
$755M
$1.23M 0.06%
32,400
-19,200
-37% -$669K
JBTM
231
JBT Marel
JBTM
$6.39B
$1.23M 0.06%
12,500
+600
+5% +$53.3K
AOS icon
232
A.O. Smith
AOS
$8.7B
$1.16M 0.06%
20,600
+2,000
+11% +$108K
PRAH
233
DELISTED
PRA Health Sciences, Inc.
PRAH
$1.14M 0.06%
15,200
-4,000
-21% -$277K
MRCY icon
234
Mercury Systems
MRCY
$6.52B
$1.13M 0.06%
26,800
– –
PAYC icon
235
Paycom
PAYC
$9.69B
$1.11M 0.05%
16,300
+5,800
+55% +$373K
ILG
236
DELISTED
ILG, Inc Common Stock
ILG
$1.1M 0.05%
+40,000
New +$1.01M
TVTY
237
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$1.1M 0.05%
+27,500
New +$920K
AVNT icon
238
Avient
AVNT
$4.19B
$1.03M 0.05%
+26,600
New +$990K
WIX icon
239
WIX.com
WIX
$2.52B
$1.03M 0.05%
14,800
+1,600
+12% +$120K
PODD icon
240
Insulet
PODD
$9.79B
$1.02M 0.05%
19,800
– –
CVLT icon
241
Commault Systems
CVLT
$5.61B
$1M 0.05%
+17,800
New +$974K
BIO icon
242
Bio-Rad Laboratories Class A
BIO
$9.42B
$996K 0.05%
4,400
– –
BCPC
243
Balchem Corp
BCPC
$5.72B
$987K 0.05%
12,700
+7,500
+144% +$598K
TREX icon
244
Trex
TREX
$5.01B
$981K 0.05%
58,000
– –
NWE icon
245
NorthWestern Energy
NWE
$4.43B
$952K 0.05%
15,600
– –
FELE icon
246
Franklin Electric
FELE
$4.84B
$948K 0.05%
22,900
-900
-4% -$36.1K
BLKB icon
247
Blackbaud
BLKB
$2.08B
$918K 0.05%
10,700
+6,400
+149% +$525K
COHR
248
DELISTED
Coherent Inc
COHR
$900K 0.04%
4,000
– –
BOBE
249
DELISTED
Bob Evans Farms, Inc.
BOBE
$869K 0.04%
12,100
+1,500
+14% +$103K
LFUS icon
250
Littelfuse
LFUS
$11.6B
$858K 0.04%
+5,200
New +$835K
8 9
10
11 12

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

EULAV Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, EULAV Asset Management held 318 positions worth $2.04B, up 4% from $1.96B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

EULAV Asset Management's Q2 2017 filing shows 26 new, 78 increased, 63 reduced and 17 closed positions. Its largest new stake was Exact Sciences: 217,000 shares worth $7.67M. The largest sale was Valspar, an estimated $12.7M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • EULAV Asset Management's largest Q2 2017 buy was Exact Sciences: 217,000 shares worth $7.67M.
  • EULAV Asset Management added most to Alexion Pharmaceuticals in Q2 2017, an estimated $18.2M increase.
  • EULAV Asset Management's biggest Q2 2017 reduction was Hormel Foods, cutting an estimated $5.4M.
  • EULAV Asset Management fully exited Valspar in Q2 2017, selling an estimated $12.7M.
  • EULAV Asset Management's ten largest holdings make up 17% of its $2.04B portfolio in Q2 2017.
  • EULAV Asset Management opened 26 new positions and closed 17 in Q2 2017.
  • EULAV Asset Management's portfolio value rose 4% quarter-over-quarter to $2.04B.

Based on EULAV Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.